PSTV Insider Trading
PLUS THERAPEUTICS, INC. | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at PLUS THERAPEUTICS, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-05 16:30 | 2025-11-04 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $0.51 | 20,000 | $10,200 | 68,138 | +41.5% |
| 2025-08-25 14:30 | 2025-08-22 | Lenk Robert P | Director | BUY | $0.49 | 110,000 | $53,779 | 139,327 | +375.1% |
| 2024-09-17 14:00 | 2024-09-13 | Hawkins Richard J | Director | BUY | $1.50 | 4,000 | $5,996 | 15,188 | +35.8% |
| 2024-09-16 14:00 | 2024-09-12 | Hawkins Richard J | Director | BUY | $1.35 | 6,285 | $8,512 | 11,188 | +128.2% |
| 2024-09-13 13:04 | 2024-09-11 | Petersen Greg | Director | BUY | $1.35 | 12,500 | $16,875 | 48,921 | +34.3% |
| 2024-09-13 13:04 | 2024-09-11 | Clowes Howard | Director | BUY | $1.34 | 5,000 | $6,681 | 26,497 | +23.3% |
| 2024-09-11 13:02 | 2024-09-10 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $1.27 | 4,098 | $5,204 | 9,815 | +71.7% |
| 2024-09-11 13:02 | 2024-09-10 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $1.23 | 8,000 | $9,839 | 20,425 | +64.4% |
| 2024-05-10 14:30 | 2024-05-08 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $2.04 | 4,902 | $10,000 | 5,717 | +601.5% |
| 2024-05-10 14:30 | 2024-05-08 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $2.04 | 12,255 | $25,000 | 12,425 | +7,208.8% |
| 2024-05-10 14:30 | 2024-05-08 | Petersen Greg | Director | BUY | $2.04 | 12,255 | $25,000 | 36,421 | +50.7% |
| 2024-05-10 14:30 | 2024-05-08 | Clowes Howard | Director | BUY | $2.04 | 9,804 | $20,000 | 21,497 | +83.8% |
| 2024-05-10 14:30 | 2024-05-08 | Hawkins Richard J | Director | BUY | $2.04 | 4,902 | $10,000 | 4,903 | +490,200.0% |
| 2024-05-10 14:30 | 2024-05-08 | Lenk Robert P | Director | BUY | $2.04 | 4,167 | $8,501 | 29,327 | +16.6% |
| 2023-12-16 01:09 | 2023-11-20 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | SELL | $1.96 | 2,068 | $4,053 | 170 | -92.4% |
| 2023-11-17 15:00 | 2023-11-15 | Lenk Robert P | Director | BUY | $1.86 | 2,000 | $3,720 | 25,160 | +8.6% |
| 2023-11-15 15:00 | 2023-11-10 | Lenk Robert P | Director | BUY | $1.44 | 6,000 | $8,620 | 23,160 | +35.0% |
| 2023-11-13 15:00 | 2023-11-08 | Lenk Robert P | Director | BUY | $1.62 | 9,199 | $14,926 | 17,160 | +115.6% |
| 2023-11-08 15:00 | 2023-11-06 | Lenk Robert P | Director | BUY | $1.61 | 7,395 | $11,933 | 7,961 | +1,306.5% |
| 2023-09-15 14:00 | 2023-09-13 | Clowes Howard | Director | BUY | $1.43 | 6,993 | $10,022 | 11,693 | +148.8% |
| 2023-09-12 14:00 | 2023-09-11 | Petersen Greg | Director | BUY | $1.70 | 20,000 | $34,062 | 24,166 | +480.1% |
| 2023-06-08 14:00 | 2023-06-06 | Clowes Howard | Director | BUY | $3.98 | 1,000 | $3,980 | 4,700 | +27.0% |
| 2023-05-04 14:00 | 2023-05-03 | Clowes Howard | Director | BUY | $3.64 | 2,500 | $9,102 | 3,700 | +208.3% |
| 2023-03-07 03:40 | 2023-03-03 | Hawkins Richard J | Director | BUY | $1,000.00 | 1 | $1,000 | 1 | +100.0% |
| 2023-01-05 03:56 | 2022-12-30 | Lenk Robert P | Director | SELL | $0.31 | 1,500 | $472 | 8,500 | -15.0% |
| 2022-06-16 13:05 | 2022-06-15 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $0.65 | 5,000 | $3,240 | 33,580 | +17.5% |
| 2022-06-06 14:30 | 2022-06-02 | Clowes Howard | Director | BUY | $0.57 | 15,000 | $8,589 | 18,000 | +500.0% |
| 2022-05-19 23:15 | 2022-05-17 | Petersen Greg | Director | BUY | $0.55 | 30,000 | $16,500 | 62,500 | +92.3% |
| 2022-04-28 14:00 | 2022-04-26 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $0.68 | 2,500 | $1,710 | 28,580 | +9.6% |
| 2022-04-27 14:00 | 2022-04-26 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $0.67 | 3,000 | $2,016 | 12,230 | +32.5% |
| 2022-04-27 14:00 | 2022-04-26 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $0.69 | 5,000 | $3,450 | 26,080 | +23.7% |
| 2022-03-03 14:15 | 2022-03-01 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $1.10 | 2,000 | $2,200 | 9,230 | +27.7% |
| 2021-11-04 13:15 | 2021-11-02 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $1.86 | 1,000 | $1,864 | 7,230 | +16.1% |
| 2021-10-28 13:15 | 2021-10-27 | Petersen Greg | Director | BUY | $1.72 | 12,500 | $21,500 | 32,500 | +62.5% |
| 2021-10-27 13:15 | 2021-10-26 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $1.66 | 2,500 | $4,150 | 21,080 | +13.5% |
| 2021-10-27 13:15 | 2021-10-26 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $1.67 | 2,000 | $3,339 | 6,230 | +47.3% |
| 2021-09-15 14:30 | 2021-09-13 | Lenk Robert P | Director | BUY | $1.86 | 7,000 | $13,011 | 10,000 | +233.3% |
| 2021-07-30 01:35 | 2021-07-27 | Sims Andrew John Hugh MacIntyre | Officer - Chief Financial Officer | BUY | $1.98 | 4,230 | $8,357 | 4,230 | +100.0% |
| 2021-05-03 13:15 | 2021-04-30 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $2.28 | 2,183 | $4,970 | 18,580 | +13.3% |
| 2021-03-05 14:15 | 2021-03-04 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $2.50 | 2,500 | $6,250 | 16,397 | +18.0% |
| 2021-03-04 14:15 | 2021-03-03 | Clowes Howard | Director | BUY | $2.42 | 3,000 | $7,260 | 3,000 | +100.0% |
| 2020-12-14 14:05 | 2020-12-10 | HEDRICK MARC H | Director, Officer - Chief Executive Officer | BUY | $1.99 | 2,500 | $4,975 | 13,867 | +22.0% |
| 2020-12-02 15:00 | 2020-11-30 | HEDRICK MARC H | Officer - Chief Executive Officer | BUY | $2.14 | 2,200 | $4,708 | 11,367 | +24.0% |
| 2020-08-26 13:05 | 2020-08-25 | Lenk Robert P | Director | BUY | $2.49 | 3,000 | $7,465 | 3,000 | +100.0% |
| 2020-08-14 13:05 | 2020-08-13 | Petersen Greg | Director | BUY | $2.80 | 10,000 | $28,000 | 20,000 | +100.0% |
| 2020-08-13 13:05 | 2020-08-12 | Petersen Greg | Director | BUY | $2.52 | 10,000 | $25,200 | 10,000 | +100.0% |
| 2020-08-13 13:00 | 2020-08-12 | HEDRICK MARC H | Officer - Chief Executive Officer | BUY | $2.58 | 4,000 | $10,318 | 9,167 | +77.4% |
| 2020-06-24 02:10 | 2020-06-22 | HEDRICK MARC H | Officer - Chief Executive Officer | BUY | $2.10 | 5,000 | $10,500 | 5,167 | +2,994.0% |
| 2005-12-02 03:56 | 2005-11-29 | COX MARSHALL G | Director | SELL | $8.22 | 20,957 | $172,267 | 521,659 | -3.9% |
| 2005-11-22 00:54 | 2005-11-17 | COX MARSHALL G | Director | SELL | $8.88 | 22,500 | $199,751 | 542,616 | -4.0% |
How to Interpret $PSTV Trades
Not every insider transaction in PLUS THERAPEUTICS, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PSTV shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for PSTV
Insider activity data for PLUS THERAPEUTICS, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PSTV, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.